A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Ruperto, Nicolino; J. Lovell, Daniel; Cuttica, Rubén; Wilkinson, Nick; Woo, Patricia; Espada, Graciela; Wouters, Carine; D. Silverman, Earl; J. Balogh, Zsolt; Henrickson, Michael; Apaz, Maria‐Teresa; Baildam, Eileen; Fasth, Anders; Gerloni, V.; Lahdenne, Pekka; Prieur, Anne‐Marie; Ravelli, Angelo; K. Saurenmann, Rotraud; Luz Gámir Gámir, María; Wulffraat, Nico; Maródi, László; E. Petty, Ross; Joos, Rik; Zulian, Francesco; McCurdy, Deborah; L. Myones, Barry; Nagy, Kálmán; D. Reuman, Peter; S. Szer, Ilona; Travers, Suzanne; Beutler, Anna; Keenan, Greg; Clark, Jason; Visvanathan, Sudha; A. Fasanmade, Adedigbo; Raychaudhuri, Aparna; Mendelsohn, Alan; Martini, Alberto; H. Giannini, Edward

doi:10.1002/art.22838

Public

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Published in Arthritis & Rheumatism • Aug 30, 2007

Authors:

Nicolino Ruperto

Daniel J. Lovell

Rubén Cuttica

Abstract

OBJECTIVE: To evaluate the safety and efficacy of infliximab in the treatment of juvenile rheumatoid arthritis (JRA). METHODS: This was an international, multicenter, randomized, placebo-controlled, double-blind study. One hundred twenty-two children with persistent polyarticular JRA despite prior m...

Subject

Infliximab

Medicine

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!